The Gene Therapy Medical Affairs Summit is set to unite leading decision-makers from both large pharma and biotech in Medical Affairs, Market Access & HEOR to tackle the greatest roadblocks facing medical affairs professionals in the gene therapy space.
Bringing together the who’s-who of medical affairs in gene therapy, this meeting will give you the opportunity to virtually connect with industry leaders to collaboratively overcome the field’s greatest challenges and offer improved solutions to the industries problems. The FDA expects 40-60 gene therapy candidates to be approved in the US alone before the year 2030. Every single one of the companies developing these candidates will need to equip themselves for a successful launch in what remains unchartered territory.
Perhaps the greatest weapon any drug developer can equip themselves with in order to achieve a successful launch is an effective medical affairs group. Medical affairs professionals face a plethora of novel challenges that are wholly unique to the gene therapy space.
This is your opportunity to provide expertise and experience to guide medical affairs professionals from clinical trials through to launch.
- Showcase your expertise to leading organizations by securing a virtual exhibition booth
- Secure a spot on our expert speaker faculty to demonstrate thought leadership and drive brand exposure
- Maximize the balance of 2:1 live content and targeted online networking to generate leads and build new relationships with gene therapy medical affairs pioneers
- Embrace the tech to meet your 2020 commercial objectives and educate decision-makers on how your expertise can deliver gene therapies to patients more effectively
Want to discuss further? Get in touch for more information.